| 产品名称 | Peptides EP12208_1 | HPV 16 E6 52-61 (HLA-B*35:01) |
|---|---|
| 目录号 | EP12208_1 |
| 别名 | HPV 16 E6 52-61 (HLA-B*35:01) |
| 外观 | 见COA |
| 分子量 | N/A |
| CAS | N/A |
| 溶解度 | |
| 存储条件 | 见COA |
| 保存时间 | 见COA |
| 备注1 | |
| 备注2 |
| 目录号 | 规格 | 价格 | 库存状态 | |
| EP12208_1 | 1 mg; 5 mg | 咨询 | 咨询 |
Peptides EP12208_1 | HPV 16 E6 52-61 (HLA-B*35:01)
品名：HPV 16 E6 52-61 (HLA-B*35:01)
货号：EP12208_1
规格：1 mg; 5 mg
品牌：Peptides.de
产品描述
FAFRDLCIVY is a linear peptidic epitope (epitope ID 110575) studied as part of Protein E6 (UniProt:P03126) from Humanes Papillomvirus 16 (HPV-16). This epitope has been studied for immune reactivity and has been tested in T cell assays and an MHC ligand assay. The high-risk HPV-16 is known for its association with cervical cancers and other anogenital cancers. HPV-16 is part of the Alphapapillomavirus 9 group, which also includes HPV-31, HPV-33, HPV-35, HPV-52, HPV-58 and HPV-67.
| Protein | Protein E6 |
| Species | HPV 16 |
| Application | Flow Cytometry, Immunohistochemistry |
| Indication | Infectious disease, Cancer |
